Inovio Pharmaceuticals, Inc. (INO) financial statements (2022 and earlier)
Company profile
| Business Address |
6769 MESA RIDGE RD. SAN DIEGO, CA 92121 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 401 | 412 | 90 | 81 | 127 | 105 | 163 | ||
| Cash and cash equivalents | 71 | 251 | 22 | 24 | 24 | 19 | 58 | ||
| Short-term investments | 330 | 161 | 67 | 58 | 104 | 86 | 105 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | (0) | (0) | (0) | (0) | |||||
| Receivables | 8 | 19 | 2 | 4 | 6 | 17 | 7 | ||
| Prepaid expense | 11 | 5 | |||||||
| Other undisclosed current assets | 28 | 36 | 3 | 3 | 4 | 3 | 2 | ||
| Total current assets: | 448 | 471 | 94 | 88 | 138 | 125 | 172 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 12 | 13 | 14 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 17 | 11 | 13 | 16 | 18 | 9 | 7 | ||
| Long-term investments and receivables | 0 | 9 | 9 | 16 | 15 | ||||
| Long-term investments | 0 | 9 | 9 | 16 | 15 | ||||
| Intangible assets, net (including goodwill) | 13 | 14 | 14 | 15 | 17 | 18 | 14 | ||
| Goodwill | 11 | 11 | 11 | 11 | 11 | 11 | 10 | ||
| Intangible assets, net (excluding goodwill) | 3 | 3 | 4 | 5 | 6 | 8 | 4 | ||
| Other noncurrent assets | 1 | 26 | 3 | 3 | 3 | 2 | 1 | ||
| Other undisclosed noncurrent assets | 4 | 4 | 6 | 0 | 2 | 4 | 5 | ||
| Total noncurrent assets: | 47 | 69 | 50 | 43 | 49 | 49 | 42 | ||
| TOTAL ASSETS: | 496 | 540 | 144 | 131 | 187 | 174 | 214 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 48 | 21 | 18 | 23 | 23 | 20 | 13 | ||
| Accrued liabilities | 6 | 9 | 6 | 3 | |||||
| Employee-related liabilities | 16 | 13 | 9 | 9 | 8 | 7 | 4 | ||
| Other undisclosed accounts payable and accrued liabilities | 32 | 8 | 9 | 8 | 7 | 7 | 6 | ||
| Deferred revenue | 0 | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 2 | ||||||||
| Deferred rent credit | 1 | ✕ | ✕ | ✕ | |||||
| Due to related parties | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 2 | 15 | 14 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | 0 | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 18 | 20 | 11 | 10 | 9 | 8 | 4 | ||
| Total current liabilities: | 66 | 42 | 32 | 35 | 35 | 44 | 31 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 15 | 18 | 20 | ||||||
| Operating lease, liability | 15 | 18 | 20 | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 0 | 0 | 9 | 9 | 9 | 6 | 6 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 9 | 6 | 6 | ||
| Deferred revenue | 0 | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | 0 | ✕ | ✕ | ✕ | ||
| Deferred rent credit | 9 | ✕ | ✕ | ✕ | |||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | 0 | 0 | ||||
| Deferred income tax liabilities | 0 | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Other liabilities | 0 | 0 | 0 | 0 | |||||
| Derivative instruments and hedges, liabilities | 9 | ||||||||
| Other undisclosed noncurrent liabilities | 15 | 19 | 77 | 0 | 0 | 0 | 1 | ||
| Total noncurrent liabilities: | 31 | 37 | 107 | 9 | 9 | 7 | 6 | ||
| Total liabilities: | 96 | 79 | 139 | 44 | 45 | 50 | 38 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 400 | 461 | 3 | 87 | 142 | 123 | 176 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 1,610 | 1,367 | 743 | 708 | 666 | 557 | 534 | ||
| Accumulated other comprehensive income (loss) | (0) | (0) | 0 | (1) | (0) | 1 | 3 | ||
| Accumulated deficit | (1,210) | (906) | (740) | (620) | (523) | (435) | (361) | ||
| Stockholders' equity attributable to noncontrolling interest | 2 | 0 | 0 | 0 | 0 | ||||
| Total stockholders' equity: | 400 | 461 | 5 | 87 | 142 | 123 | 176 | ||
| TOTAL LIABILITIES AND EQUITY: | 496 | 540 | 144 | 131 | 187 | 174 | 214 | ||
Income statement (P&L) ($ in millions)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 3 | 7 | 4 | 30 | 42 | 35 | 41 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 42 | 35 | 41 | |
| Net investment income | 3 | 3 | 3 | |||||
| Gross profit: | 3 | 7 | 4 | 30 | 42 | 35 | 41 | |
| Operating expenses | (303) | (131) | (115) | (125) | (126) | (112) | (75) | |
| Other undisclosed operating loss | (2) | |||||||
| Operating loss: | (301) | (124) | (111) | (94) | (84) | (76) | (34) | |
| Nonoperating income | 0 | 3 | 0 | |||||
| Investment income, nonoperating | 4 | |||||||
| Other nonoperating income (expense) | 0 | (1) | 0 | |||||
| Interest and debt expense | (2) | (9) | (8) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (303) | (129) | (119) | (94) | (84) | (76) | (34) | |
| Other undisclosed income (loss) from continuing operations before income taxes | (0) | (34) | (2) | (1) | (5) | 2 | 3 | |
| Loss from continuing operations before income taxes: | (303) | (163) | (121) | (95) | (88) | (74) | (31) | |
| Income tax expense (benefit) | 0 | (2) | 2 | |||||
| Loss before gain (loss) on sale of properties: | (303) | (163) | (121) | (97) | (88) | (74) | (29) | |
| Other undisclosed net loss | (0) | (5) | ||||||
| Net loss: | (304) | (167) | (121) | (97) | (88) | (74) | (29) | |
| Net income (loss) attributable to noncontrolling interest | 1 | 1 | (0) | |||||
| Net loss attributable to parent: | (304) | (166) | (119) | (97) | (88) | (74) | (29) | |
| Other undisclosed net loss available to common stockholders, basic | (1) | (1) | ||||||
| Net loss available to common stockholders, diluted: | (304) | (166) | (119) | (97) | (89) | (74) | (30) | |
Comprehensive Income ($ in millions)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (304) | (167) | (121) | (97) | (88) | (74) | (29) | |
| Other comprehensive income | 0 | |||||||
| Other undisclosed comprehensive income (loss) | (0) | (1) | 1 | (0) | (1) | (1) | 3 | |
| Comprehensive loss: | (304) | (168) | (120) | (97) | (90) | (75) | (26) | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 1 | 1 | (0) | |||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 0 | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (304) | (167) | (118) | (97) | (90) | (75) | (26) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.